Back
The New York Times Co. Vs. Viking Therapeutics, Inc. Industry Stock Comparison
Buy
85
NYT
The New York Times Co.
Last Price:
$70.71
Seasonality Move:
5.79%
Sell
43
VKTX
Viking Therapeutics, Inc.
Last Price:
$36.43
Seasonality Move:
33.2%
Buy
85
The New York Times Co. (NYT)
is a Buy
Is The New York Times Co. a Buy, Sell or Hold?
-
The current The New York Times Co. [NYT] share price is $70.52. The Score for NYT is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
-
NYT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
43
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Viking Therapeutics, Inc. [VKTX] share price is $35.40. The Score for VKTX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NYT Stock Price Chart
What is The New York Times Co.'s stock price today?
-
The The New York Times Co. share price today is $70.52Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYT is experiencing slight selling pressure.
VKTX Stock Price Chart
What is Viking Therapeutics, Inc.'s stock price today?
-
The Viking Therapeutics, Inc. share price today is $35.40Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing slight buying pressure.
NYT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.24 | Buy |
| Relative Strength Index (14 RSI): | 78.76 | Buy |
| Chaikin Money Flow: | -703445 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.56 - 68.34) | Buy |
| Bollinger Bands (100): | (55.87 - 64.19) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.75 | Buy |
| Relative Strength Index (14 RSI): | 47.56 | Sell |
| Chaikin Money Flow: | 331195 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.61 - 37.59) | Sell |
| Bollinger Bands (100): | (27.52 - 37.88) | Buy |
NYT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69 | Buy |
| 20-day SMA: | 66.52 | Buy |
| 50-day SMA: | 62.09 | Buy |
| 200-day SMA: | 56.33 | Buy |
| 8-day EMA: | 69.11 | Buy |
| 20-day EMA: | 66.9 | Buy |
| 50-day EMA: | 63.53 | Buy |
| 200-day EMA: | 57.82 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.63 | Sell |
| 20-day SMA: | 36.1 | Sell |
| 50-day SMA: | 36 | Sell |
| 200-day SMA: | 30.21 | Buy |
| 8-day EMA: | 22.1 | Buy |
| 20-day EMA: | 11.47 | Buy |
| 50-day EMA: | 5.14 | Buy |
| 200-day EMA: | 1.36 | Buy |
The New York Times Co. Earnings Growth & NYT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.25 per share.
Viking Therapeutics, Inc. Earnings Growth & VKTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.65 per share, and a decrease next year of $1.11 per share.
The New York Times Co. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||